CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 92 filers reported holding CUE BIOPHARMA INC in Q2 2021. The put-call ratio across all filers is 2.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $4,154,000 | -46.6% | 285,133 | -57.3% | 0.07% | -53.1% |
| Q2 2021 | $7,773,000 | +214.2% | 667,224 | +229.0% | 0.14% | +163.6% |
| Q1 2021 | $2,474,000 | -61.2% | 202,806 | -60.2% | 0.06% | -67.5% |
| Q4 2020 | $6,381,000 | -53.6% | 510,088 | -44.2% | 0.17% | -62.5% |
| Q3 2020 | $13,766,000 | -14.8% | 914,662 | +38.7% | 0.45% | -29.5% |
| Q2 2020 | $16,162,000 | – | 659,395 | – | 0.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,545,573 | $3,447,000 | 1.85% |
| P.A.W. CAPITAL CORP | 200,000 | $446,000 | 0.67% |
| SANDERS MORRIS HARRIS LLC | 848,048 | $2,020,000 | 0.50% |
| Monaco Asset Management SAM | 458,851 | $1,023,000 | 0.39% |
| Bleichroeder LP | 555,000 | $1,238,000 | 0.26% |
| APOGEM CAPITAL LLC | 110,614 | $247,000 | 0.25% |
| Slate Path Capital LP | 1,483,619 | $3,308,000 | 0.22% |
| Voss Capital, LLC | 200,000 | $446,000 | 0.13% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $1,067,000 | 0.11% |
| CARLSON CAPITAL L P | 535,000 | $1,193,000 | 0.09% |